Purdue Pharma
Purdue Pharma started as the Purdue Frederick Company in 1892. It was an American privately held pharmaceutical company in New York. Arthur, Mortimer, and Raymond Sackler bought it in 1952. They concentrated on pain management and advertised their drugs to doctors. Purdue Pharma L.P was created in 1991.[1]
In 1996, Purdue Pharma started selling OxyContin, a new version of oxycodone, an opioid. It was approved by the FDA in 1995 after no long-term studies and no assessment of how addictive it was.[2] Their advertising to doctors was very effective. The drug was very successful and made US$35 billion for Purdue.[3] It is very easy to be addicted to it. From 1999 to 2020 opioids killed about 500,000 people in the USA. [4]
In 2007 the company was fined $634.5 million for misleading people about how addictive OxyContin was compared to other pain medicine.[5] They carried on selling opioids until 2019. The company and the Sackler family were sued by hundreds of people and many American states.[6] The company filed for bankruptcy.[7]
References
[change | change source]- ↑ Sales, Ben (2019-05-22). "Who are the Sacklers, the family at the center of the opioid crisis?". Jewish Telegraphic Agency. Retrieved 2023-10-17.
- ↑ "Confirmation Hearing for FDA Commissioner Nominee". C-SPAN. 14 December 2021. Retrieved 12 December 2022.
- ↑ "The Family That Built an Empire of Pain". The New Yorker. 23 October 2017. Archived from the original on 22 January 2018. Retrieved 2 February 2019.
- ↑ "Prescription Opioids | Opioids | CDC". www.cdc.gov. 2021-10-02. Retrieved 2023-10-17.
- ↑ AP (2007-05-10). "Purdue Pharma, Execs to Pay $634.5 Million Fine in OxyContin Case". www.cnbc.com. Retrieved 2023-10-17.
- ↑ Hakim, Danny; Rabin, Roni Caryn; Rashbaum, William K. (2019-04-01). "Lawsuits Lay Bare Sackler Family's Role in Opioid Crisis". The New York Times. ISSN 0362-4331. Retrieved 2023-10-17.
- ↑ Knauth, Dietrich (2023-07-25). "Purdue Pharma bankruptcy can proceed despite potential US Supreme Court appeal". Reuters. Retrieved 2023-10-17.